SMS Lifesciences India Limited (SMSLIFE) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.161x

Based on the latest financial reports, SMS Lifesciences India Limited (SMSLIFE) has a cash flow conversion efficiency ratio of 0.161x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs340.55 Million ≈ $3.68 Million USD) by net assets (Rs2.12 Billion ≈ $22.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

SMS Lifesciences India Limited - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how SMS Lifesciences India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SMS Lifesciences India Limited balance sheet liabilities for a breakdown of total debt and financial obligations.

SMS Lifesciences India Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SMS Lifesciences India Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Nirvana Daii Public Company Limited BK:NVD	0.045x
3I Infrastructure PLC LSE:3IN	-0.006x
374Water Inc. Common Stock NASDAQ:SCWO	-0.398x
Lotte Chilsung Beverage Co Ltd KO:005305	0.093x
Exel Composites Oyj HE:EXL1V	0.102x
Osangjaiel Co. Ltd KQ:053980	0.010x
Ta Jiang Co Ltd TW:1453	-0.067x
TPBI PCL BK:TPBI	0.059x

Annual Cash Flow Conversion Efficiency for SMS Lifesciences India Limited (2016–2025)

The table below shows the annual cash flow conversion efficiency of SMS Lifesciences India Limited from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see how much is SMS Lifesciences India Limited worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs2.12 Billion ≈ $22.93 Million	Rs298.10 Million ≈ $3.22 Million	0.141x	+12.00%
2024-03-31	Rs1.94 Billion ≈ $20.94 Million	Rs243.06 Million ≈ $2.63 Million	0.126x	+14010783.13%
2023-03-31	Rs1.64 Billion ≈ $17.74 Million	Rs1.47K ≈ $15.89	0.000x	+100.00%
2022-03-31	Rs1.65 Billion ≈ $17.84 Million	Rs-112.41 Million ≈ $-1.22 Million	-0.068x	-125.04%
2021-03-31	Rs1.29 Billion ≈ $13.97 Million	Rs351.70 Million ≈ $3.80 Million	0.272x	+116.54%
2020-03-31	Rs1.16 Billion ≈ $12.52 Million	Rs145.47 Million ≈ $1.57 Million	0.126x	-55.44%
2019-03-31	Rs1.06 Billion ≈ $11.50 Million	Rs299.93 Million ≈ $3.24 Million	0.282x	+211.71%
2018-03-31	Rs884.08 Million ≈ $9.56 Million	Rs80.00 Million ≈ $865.21K	0.090x	-63.89%
2017-03-31	Rs808.34 Million ≈ $8.74 Million	Rs202.60 Million ≈ $2.19 Million	0.251x	-11.86%
2016-03-31	Rs691.28 Million ≈ $7.48 Million	Rs196.59 Million ≈ $2.13 Million	0.284x	--

About SMS Lifesciences India Limited

NSE:SMSLIFE India Biotechnology

Market Cap

$42.13 Million

Rs3.90 Billion INR

Market Cap Rank

#22513 Global

#1255 in India

Share Price

Rs1288.50

Change (1 day)

-6.64%

52-Week Range

Rs1078.80 - Rs1453.00

All Time High

Rs1747.88